Clinical Development of an Opioid Minimizing Combination Therapeutic

NCBiotech Grants & Loans

See the full listing of all NCBiotech grants and loans awarded since July 2012.

Amalgent Therapeutics
Award Date
Award Amount
Program Name
Small Business Research Loan
Program Category
Business Financing
Principal Investigator
Malcolm Meyn
Fiscal Year
Project Description:

Amalgent Therapeutics (Greenville, NC) is seeking 505(b)(2) approval for a fixed-dose oral tablet combination of two FDA approved drugs, morphine and pramipexole, that enables reduction of morphine to a less addictive dose. The SRL funds will be used to perform animal studies and prepare for a pre-IND meeting.

scroll back to top of page